Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients

作     者：Xin Zhang Shu-Zhen Wang Jun-Fu Zheng Wen-Min Zhao Peng Li Chun-Lei Fan Bing Li Pei-Ling Dong Lei Li Hui-Guo Ding 

作者机构：Department of Gastroenterology and Hepatology Beijing You’an Hospital Affiliated with Capital Medical University 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2014年第20卷第32期

页      面：11400-11405页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Supported by The Program of Beijing Science and Technology Commission,No.D131100005313004 the Beijing HighLevel Talent Academic Leader/Personnel Training Programs awarded to Ding HG,2011-2-19 Li B,2013-3-072 and Li L,2013-3-073 

主　　题：Tolvaptan Refractory ascites Hyponatremia Decompensation Liver cirrhosis 

摘      要：AIM: To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular carcinoma.